|
Q3 2023
|
65 |
296,845 |
AMGN, INCY, GILD, ITCI
|
13F-HR
|
11/14/2023 |
000095012323010374 |
|
Q2 2023
|
61 |
328,500 |
AMGN, INCY, HRMY, REGN
|
13F-HR
|
8/8/2023 |
000095012323006845 |
|
Q1 2023
|
64 |
358,401 |
SGEN, AMGN, INCY, HRMY
|
13F-HR
|
5/18/2023 |
000095012323005544 |
|
Q4 2022
|
63 |
323,783 |
HORIZON THERAPEUTICS PLC, SGEN, INCY, ALKS
|
13F-HR
|
2/1/2023 |
000095012323000575 |
|
Q3 2022
|
66 |
311,859 |
HORIZON THERAPEUTICS, SGEN, INCY, ALKS
|
13F-HR
|
11/8/2022 |
000095012322011064 |
|
Q2 2022
|
78 |
9,586 |
CNCE, AUPH, DYN, I-MAB SPONSORED ADS
|
13F-HR
|
8/16/2022 |
000095012322009585 |
|
Q1 2022
|
70 |
443,419 |
AMGN, PRTA, ALNY, ITCI
|
13F-HR
|
5/20/2022 |
000095012322006648 |
|
Q4 2021
|
73 |
448,857 |
AMGN, NBIX, ALNY, INCY
|
13F-HR
|
2/15/2022 |
000095012322003118 |
|
Q3 2021
|
69 |
414,612 |
GILD, NBIX, HORIZON THERAPEUTICS PUB LTD, AMGN
|
13F-HR
|
11/12/2021 |
000095012321014818 |
|
Q2 2021
|
67 |
378,776 |
GILD, ALNY, SGEN, HORIZON THERAPEUTICS PUB LTD
|
13F-HR
|
8/11/2021 |
000095012321010210 |
|
Q1 2021
|
56 |
378,079 |
HZNP, GILD, REGN, NBIX
|
13F-HR
|
5/17/2021 |
000095012321006820 |
|
Q4 2020
|
52 |
366,148 |
HZNP, ACAD, VRTX, BMRN
|
13F-HR
|
2/19/2021 |
000095012321003010 |
|
Q3 2020
|
53 |
309,768 |
HZNP, NBIX, GILD, ACAD
|
13F-HR
|
12/1/2020 |
000095012320012421 |
|
Q2 2020
|
53 |
300,837 |
HZNP, BMRN, GILD, VRTX
|
13F-HR
|
7/14/2020 |
000095012320006966 |
|
Q1 2020
|
56 |
219,373 |
VRTX, GILD, BIIB, BMRN
|
13F-HR
|
5/18/2020 |
000095012320005438 |
|
Q4 2019
|
63 |
277,590 |
VRTX, GILD, AMGN, ACAD
|
13F-HR
|
5/18/2020 |
000095012320005437 |
|
Q3 2019
|
58 |
216,398 |
GILD, CELG, VRTX, NBIX
|
13F-HR
|
11/14/2019 |
000095012319010938 |
|
Q2 2019
|
64 |
269,707 |
GILD, VRTX, NBIX, CELG
|
13F-HR
|
8/14/2019 |
000095012319007894 |
|
Q1 2019
|
62 |
270,681 |
CELG, GILD, REGN, STML
|
13F-HR
|
5/14/2019 |
000095012319004815 |
|
Q4 2018
|
45 |
161,145 |
INCY, VRTX, CELG, GILD
|
13F-HR
|
2/14/2019 |
000095012319001968 |
|
Q3 2018
|
51 |
210,406 |
CELG, ILMN, INCY, VRTX
|
RESTATEMENT
|
11/14/2018 |
000095012318011833 |
|
Q2 2018
|
54 |
260,427 |
NBIX, CELG, VRTX, ILMN
|
13F-HR
|
8/13/2018 |
000095012318008109 |
|
Q1 2018
|
63 |
256,338 |
CELG, SHPG, ARRY, NBIX
|
13F-HR
|
5/15/2018 |
000095012318005420 |
|
Q4 2017
|
65 |
283,639 |
BIIB, CELG, REGN, NKTR
|
13F-HR
|
3/2/2018 |
000095012318002800 |
|
Q3 2017
|
56 |
256,889 |
CELG, BIIB, REGN, VRTX
|
13F-HR
|
3/2/2018 |
000095012318002805 |
|
Q2 2017
|
60 |
263,163 |
REGN, CELG, VRTX, BIIB
|
13F-HR
|
3/2/2018 |
000095012318002803 |
|
Q1 2017
|
60 |
261,246 |
CELG, BIIB, REGN, INCY
|
13F-HR
|
3/2/2018 |
000095012318002801 |
|
Q4 2016
|
49 |
221,987 |
CELG, BIIB, ALXN, SHPG
|
13F-HR
|
3/2/2018 |
000095012318002802 |